公开(公告)号：US10028967B2

公开(公告)日：2018-07-24

申请号：US15324457

申请日：2015-06-27

Applicant: Symrise AG

Inventor： Donna Rosa ,  Jakob Ley ,  Gerhard Krammer ,  Deborah Kennison

IPC: A61K31/616 ,  A61K31/485 ,  A61K31/192 ,  A61K31/167 ,  A61K31/137 ,  A61K9/00 ,  A61K47/10 ,  A61K31/09 ,  A23L33/10

Abstract: Suggested is a medicament which is particularly useful for preventing, curing or abating of cough and inflammations of the respiratory system, comprising or consisting of active pharmaceutical ingredients and 1,3-propandiol.

公开(公告)号：US20170196898A1

公开(公告)日：2017-07-13

申请号：US15324457

申请日：2015-06-27

Applicant: Symrise AG

Inventor： Donna Rosa ,  Jakob Ley ,  Gerhard Krammer ,  Deborah Kennison

IPC: A61K31/616 ,  A61K47/10 ,  A61K31/485 ,  A23L33/10 ,  A61K31/167 ,  A61K31/137 ,  A61K31/09 ,  A61K9/00 ,  A61K31/192

CPC classification number: A61K31/616 ,  A23L33/10 ,  A23V2002/00 ,  A61K8/345 ,  A61K8/36 ,  A61K8/37 ,  A61K8/41 ,  A61K8/42 ,  A61K8/4926 ,  A61K8/4946 ,  A61K9/0056 ,  A61K9/0058 ,  A61K9/0095 ,  A61K31/09 ,  A61K31/137 ,  A61K31/167 ,  A61K31/192 ,  A61K31/485 ,  A61K47/10 ,  A61Q11/00 ,  A61K2300/00

Abstract: Suggested is a medicament which is particularly useful for preventing, curing or abating of cough and inflammations of the respiratory system, comprising or consisting of active pharmaceutical ingredients and 1,3-propandiol.

公开(公告)号：US09629795B2

公开(公告)日：2017-04-25

申请号：US14672843

申请日：2015-03-30

Applicant: Symrise AG

Inventor： Gerhard Krammer ,  Sven Siegel ,  Deborah Kennison

IPC: A61K8/97 ,  A61K8/31 ,  A61Q11/00 ,  A23G3/36 ,  A23L3/3463 ,  A23L1/235 ,  A61K8/34 ,  A23L2/52 ,  A23L2/60 ,  A23G3/48 ,  A23G4/06 ,  A23L27/00 ,  A23L27/12 ,  A23L27/29 ,  A23L27/30

CPC classification number: A61K8/97 ,  A23G3/36 ,  A23G3/48 ,  A23G4/06 ,  A23G4/068 ,  A23L2/52 ,  A23L2/60 ,  A23L27/13 ,  A23L27/29 ,  A23L27/36 ,  A23L27/70 ,  A23L27/72 ,  A61K8/31 ,  A61K8/345 ,  A61Q11/00

Abstract: Substance mixtures are proposed, comprising (a) terpenes, (b) propane-1,3-diol, and optionally (c) active substances selected from the group consisting of (c1) rebaudiosides or plant extracts comprising them, (c2) steviosides or plant extracts comprising them, (c3) monatin, (c4) naringin, (c5) chalcones and hydrochalcones, (c6) mogrosides or plant extracts comprising them, (c7) rubusosides or plant extracts comprising them, and (c8) glycyrrhizic acid or plant extracts comprising it.